Yuntao Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yuntao Wang has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Juan Wang
Gaochun People’s Hospital
2 shared publicationsLei Liu
Department of Spine Surgery, Affiliated ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China
2 shared publicationsLong Lv
Central Laboratory, Gaochun Hospital Affiliated to Jiangsu University, Nanjing, Jiangsu, 211300, China
2 shared publicationsPengfei Xue
Medical School of Southeast University, Nanjing, Jiangsu, 210009, China
2 shared publicationsRui Sun
Department of Spine Surgery, Affiliated ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China
2 shared publicationsAi-Hua Xu
Gaochun People’s Hospital
1 shared publication
Latest Publications
- Open Access
- 23 March 2026
- Published by Springer Nature in Cellular & Molecular Biology Letters
- Vol. 31
Macrophage-derived legumain ameliorates excessive mechanical stress-induced ferroptosis of nucleus pulposus cells and intervertebral disc degeneration via integrin αvβ3–Hippo signaling
Excessive mechanical stress is a major cause of intervertebral disc degeneration (IVDD). Macrophages can sense physical signals, but their role in respondi
- 23 March 2026
- Published by Springer Nature in Cellular & Molecular Biology Letters
- Vol. 31
Open AccessMacrophage-derived legumain ameliorates excessive mechanical stress-induced ferroptosis of nucleus pulposus cells and intervertebral disc degeneration via integrin αvβ3–Hippo signaling
Excessive mechanical stress is a major cause of intervertebral disc degeneration (IVDD). Macrophages can sense physical signals, but their role in respondi
- 23 March 2026
- Published by Springer Nature in Current Medical Science
- p. 1-20
Efficacy and Mechanisms of Duhuo Jisheng Decoction in Treating Intervertebral Disc Degeneration: A Network Pharmacology and Experimental Study
Objective Intervertebral disc degeneration (IDD) is the main cause of low back pain, which is closely related to an imbalance in extracellular matrix decomposition–anabolism mediated by immune inflammation. Duhuo Jisheng decoction (DHJSD) is effective in treating IDD, but its specific mechanism of action remains unclear and warrants further study. This study aimed to investigate the role of DHJSD in IDD treatment and its underlying mechanisms of action, providing potential therapeutic targets for IDD. Methods High-performance liquid chromatography‒mass spectrometry (HPLC‒MS/MS) was employed to characterize the chemical composition of DHJSD. A Cell Counting Kit-8 (CCK-8) was used to detect the effects of DHJSD on the viability of pressure-treated nucleus pulposus (NP) cells. NP cells were randomly divided into three groups: control, pressure, and DHJSD groups. Western blotting was used to detect the expression of NLRP3, ASC, caspase-1, IL-1β, collagen II, aggrecan, Sox-9, MMP-3, MMP-13, and Adamts-4 in the aforementioned three groups of cells. An immunofluorescence assay was used to detect NLRP3 expression. Additional groups included the DHJSD + dimethyl sulfoxide (DMSO) and DHJSD + cyclosporine A groups. The expression of mitophagy-related factors, the NLRP3 inflammasome, and subsequent inflammatory reactions were detected by Western blotting and immunofluorescence. Network pharmacology and molecular docking were used to explore the key components and key genes of DHJSD involved in treating IDD. Finally, we verified the bioinformatics results using a rat tail acupuncture model of IDD. Results DHJSD-containing serum improved NP cell viability; the optimal intervention concentration was 20% by volume, and the optimal intervention time was 24 h. Compared with the pressure group, the DHJSD group presented significantly decreased expression of NLRP3, ASC, caspase-1, IL-1β, MMP-3, MMP-13, Adamts-4, and p62, and significantly increased expression of collagen II, aggrecan, Sox-9, PINK1, Parkin, and LC3. However, upon the addition of a mitophagy inhibitor, the protective effect of DHJSD on NP cells was diminished. Network pharmacology and molecular docking studies revealed that HIF-1α may be the key target of DHJSD in the treatment of IDD. Imaging and histopathological results confirmed that DHJSD delayed IDD progression. Western blotting and immunohistochemistry revealed that DHJSD increased HIF-1α expression, regulated mitochondrial division and fusion, and inhibited the activation of the NLRP3 inflammasome and subsequent inflammatory reactions. Conclusion DHJSD exerts a protective effect on NP cells by suppressing the activation of the NLRP3 inflammasome and subsequent imbalance in the extracellular matrix via mitophagy, which is potentially associated with the activation of the HIF-1α signaling pathway and the preservation of the metabolic balance of the mitochondria.
- 23 March 2026
- Published by Springer Nature in Current Medical Science
- p. 1-20
Efficacy and Mechanisms of Duhuo Jisheng Decoction in Treating Intervertebral Disc Degeneration: A Network Pharmacology and Experimental Study
Objective Intervertebral disc degeneration (IDD) is the main cause of low back pain, which is closely related to an imbalance in extracellular matrix decomposition–anabolism mediated by immune inflammation. Duhuo Jisheng decoction (DHJSD) is effective in treating IDD, but its specific mechanism of action remains unclear and warrants further study. This study aimed to investigate the role of DHJSD in IDD treatment and its underlying mechanisms of action, providing potential therapeutic targets for IDD. Methods High-performance liquid chromatography‒mass spectrometry (HPLC‒MS/MS) was employed to characterize the chemical composition of DHJSD. A Cell Counting Kit-8 (CCK-8) was used to detect the effects of DHJSD on the viability of pressure-treated nucleus pulposus (NP) cells. NP cells were randomly divided into three groups: control, pressure, and DHJSD groups. Western blotting was used to detect the expression of NLRP3, ASC, caspase-1, IL-1β, collagen II, aggrecan, Sox-9, MMP-3, MMP-13, and Adamts-4 in the aforementioned three groups of cells. An immunofluorescence assay was used to detect NLRP3 expression. Additional groups included the DHJSD + dimethyl sulfoxide (DMSO) and DHJSD + cyclosporine A groups. The expression of mitophagy-related factors, the NLRP3 inflammasome, and subsequent inflammatory reactions were detected by Western blotting and immunofluorescence. Network pharmacology and molecular docking were used to explore the key components and key genes of DHJSD involved in treating IDD. Finally, we verified the bioinformatics results using a rat tail acupuncture model of IDD. Results DHJSD-containing serum improved NP cell viability; the optimal intervention concentration was 20% by volume, and the optimal intervention time was 24 h. Compared with the pressure group, the DHJSD group presented significantly decreased expression of NLRP3, ASC, caspase-1, IL-1β, MMP-3, MMP-13, Adamts-4, and p62, and significantly increased expression of collagen II, aggrecan, Sox-9, PINK1, Parkin, and LC3. However, upon the addition of a mitophagy inhibitor, the protective effect of DHJSD on NP cells was diminished. Network pharmacology and molecular docking studies revealed that HIF-1α may be the key target of DHJSD in the treatment of IDD. Imaging and histopathological results confirmed that DHJSD delayed IDD progression. Western blotting and immunohistochemistry revealed that DHJSD increased HIF-1α expression, regulated mitochondrial division and fusion, and inhibited the activation of the NLRP3 inflammasome and subsequent inflammatory reactions. Conclusion DHJSD exerts a protective effect on NP cells by suppressing the activation of the NLRP3 inflammasome and subsequent imbalance in the extracellular matrix via mitophagy, which is potentially associated with the activation of the HIF-1α signaling pathway and the preservation of the metabolic balance of the mitochondria.
- 23 October 2025
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 8 (44) , 21156-21172
M2 Macrophage-Derived Small Extracellular Vesicles Alleviate IVDD by Inhibiting Nucleus Pulposus Cell Fibrosis through the Akt/FOXO1/PAI-1 Axis
- 23 October 2025
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 8 (44) , 21156-21172
M2 Macrophage-Derived Small Extracellular Vesicles Alleviate IVDD by Inhibiting Nucleus Pulposus Cell Fibrosis through the Akt/FOXO1/PAI-1 Axis
- Top Cited PapersOpen Access
- 13 May 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1) , 1-46
Biomaterial-based strategies for bone cement: modulating the bone microenvironment and promoting regeneration
Osteoporotic bone defect and fracture healing remain significant challenges in clinical practice. While traditional therapeutic approaches provide some regulation of bone homeostasis, they often present limitations and adverse effects. In orthopedic procedures, bone cement serves as a crucial material for stabilizing osteoporotic bone and securing implants. However, with the exception of magnesium phosphate cement, most cement variants lack substantial bone regenerative properties. Recent developments in biomaterial science have opened new avenues for enhancing bone cement functionality through innovative modifications. These advanced materials demonstrate promising capabilities in modulating the bone microenvironment through their distinct physicochemical properties. This review provides a systematic analysis of contemporary biomaterial-based modifications of bone cement, focusing on their influence on the bone healing microenvironment. The discussion begins with an examination of bone microenvironment pathology, followed by an evaluation of various biomaterial modifications and their effects on cement properties. The review then explores regulatory strategies targeting specific microenvironmental elements, including inflammatory response, oxidative stress, osteoblast-osteoclast homeostasis, vascular network formation, and osteocyte-mediated processes. The concluding section addresses current technical challenges and emerging research directions, providing insights for the development of next-generation biomaterials with enhanced functionality and therapeutic potential. Graphical Abstract
- 13 May 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1) , 1-46
Top Cited PapersOpen AccessBiomaterial-based strategies for bone cement: modulating the bone microenvironment and promoting regeneration
Osteoporotic bone defect and fracture healing remain significant challenges in clinical practice. While traditional therapeutic approaches provide some regulation of bone homeostasis, they often present limitations and adverse effects. In orthopedic procedures, bone cement serves as a crucial material for stabilizing osteoporotic bone and securing implants. However, with the exception of magnesium phosphate cement, most cement variants lack substantial bone regenerative properties. Recent developments in biomaterial science have opened new avenues for enhancing bone cement functionality through innovative modifications. These advanced materials demonstrate promising capabilities in modulating the bone microenvironment through their distinct physicochemical properties. This review provides a systematic analysis of contemporary biomaterial-based modifications of bone cement, focusing on their influence on the bone healing microenvironment. The discussion begins with an examination of bone microenvironment pathology, followed by an evaluation of various biomaterial modifications and their effects on cement properties. The review then explores regulatory strategies targeting specific microenvironmental elements, including inflammatory response, oxidative stress, osteoblast-osteoclast homeostasis, vascular network formation, and osteocyte-mediated processes. The concluding section addresses current technical challenges and emerging research directions, providing insights for the development of next-generation biomaterials with enhanced functionality and therapeutic potential. Graphical Abstract
- Open Access
- 9 October 2024
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 49, 119-134
Unveiling the role of CXCL8/CXCR2 in intervertebral disc degeneration: A path to promising therapeutic strategies
- 9 October 2024
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 49, 119-134
Open AccessUnveiling the role of CXCL8/CXCR2 in intervertebral disc degeneration: A path to promising therapeutic strategies
- 17 November 2023
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 28 (3) , 95-108
Roles of Chemokines in Intervertebral Disk Degeneration
Purpose of Review Intervertebral disc degeneration is the primary etiology of low back pain and radicular pain. This review examines the roles of crucial chemokines in different stages of degenerative disc disease, along with interventions targeting chemokine function to mitigate disc degeneration. Recent Findings The release of chemokines from degenerated discs facilitates the infiltration and activation of immune cells, thereby intensifying the inflammatory cascade response. The migration of immune cells into the venous lumen is concomitant with the emergence of microvascular tissue and nerve fibers. Furthermore, the presence of neurogenic factors secreted by disc cells and immune cells stimulates the activation of pain-related cation channels in the dorsal root ganglion, potentially exacerbating discogenic and neurogenic pain and intensifying the degenerative cascade response mediated by chemokines. Summary Gaining a deeper comprehension of the functions of chemokines and immune cells in these processes involving catabolism, angiogenesis, and injury detection could offer novel therapeutic avenues for managing symptomatic disc disease.
- 17 November 2023
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 28 (3) , 95-108
Roles of Chemokines in Intervertebral Disk Degeneration
Purpose of Review Intervertebral disc degeneration is the primary etiology of low back pain and radicular pain. This review examines the roles of crucial chemokines in different stages of degenerative disc disease, along with interventions targeting chemokine function to mitigate disc degeneration. Recent Findings The release of chemokines from degenerated discs facilitates the infiltration and activation of immune cells, thereby intensifying the inflammatory cascade response. The migration of immune cells into the venous lumen is concomitant with the emergence of microvascular tissue and nerve fibers. Furthermore, the presence of neurogenic factors secreted by disc cells and immune cells stimulates the activation of pain-related cation channels in the dorsal root ganglion, potentially exacerbating discogenic and neurogenic pain and intensifying the degenerative cascade response mediated by chemokines. Summary Gaining a deeper comprehension of the functions of chemokines and immune cells in these processes involving catabolism, angiogenesis, and injury detection could offer novel therapeutic avenues for managing symptomatic disc disease.